NanO2 in Large VessEL Occlusion Stroke (NOVEL)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 172 participants.
Also called NCT06821347
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 172 participants
- Registry
-
NCT06821347
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06821347. Randomized; double masking; primary purpose treatment. Start 2025-05-01 (anticipated); primary completion 2026-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NanO2 in Large VessEL Occlusion Stroke (NOVEL)
- Acronym
- NOVEL
- Condition
- Stroke Acute
- Intervention (Drug)
- NanO2TM
- Intervention (Other)
- Sodium Chloride 0.9% Intravenous
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
- Collaborator
- NuvOx LLC
Record details
- Record id
cardio:ct-nct06821347- Content hash
3707c23a7437b1264d35fbdfbf2c7962369866b70f21534ba63cbcf80227c421